Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0002007919-25-000015
Filing Date
2025-02-26
Accepted
2025-02-26 16:26:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 9135
  Complete submission text file 0002007919-25-000015.txt   10698
Mailing Address 5964 LA PLACE COURT CARLSBAD CA 92008
Business Address
Kayyem Jon Faiz (Filed by) CIK: 0001366268 (see all company filings)

Type: SCHEDULE 13D/A

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Subject) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-94527 | Film No.: 25670550
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)